Phoenix-based Translational Genomics Research Institute and Flagstaff-based Northern Arizona University received the first patent for their antibiotic-resistant staph infection detection technology, according to The Daily Courier.
Here are five key points:
1. Australia issued the patent.
2. The one-hour test is designed to accurately pinpoint Methicillin-resistant Staphylococcus aureus.
3. The technology can also detect the common antibiotic-resistant Coagulase Negative Staphylococcus.
4. Other tests do not detect CNS, which is much more common than MRSA.
5. Next, the institutions hope to receive U.S. patent approval.
